NITTOBO MEDICAL

What NITTOBO MEDICAL does

NITTOBO MEDICAL Co., Ltd. (ニットーボーメディカル株式会社) is a Japanese in vitro diagnostics manufacturer founded in August 1987 as a wholly-owned subsidiary of Nittobo Co., Ltd. (日東紡績株式会社), operating from a Tokyo headquarters with an Osaka sales branch and a Fukuyama Factory in Fukushima Prefecture. The company's core business is the research, manufacture, and sale of in vitro diagnostic pharmaceuticals — clinical chemistry and immunology reagents for automated analyzers (including TRACP-5b for bone metabolism, serum IgG4, oxidized albumin/HNA, HbA1c, CRP, LD, ALP, calcium, and iron assays), biochemical standard solutions and quality control materials, and a 300+ item research antibody catalog focused on neuroscience, flow cytometry, and infectious disease research (including alpaca-derived VHH antibodies and ACE2 monoclonals).

The company's distinguishing operational feature is a vertically integrated global value chain within the Nittobo Group: raw antisera are produced at three company-owned goat farms in California, Iowa, and Maine operated by Nittobo America Inc. (under USDA inspection), human serum calibrators and special specimens are processed and exported from the US subsidiary, and finished diagnostic kits are manufactured and distributed in Japan — a structure that has been in place since the parent began supplying synthetic substrates to IVD manufacturers in 1981. Revenue is generated primarily through direct field sales to Japanese clinical laboratories and medical institutions, direct export of antisera and diagnostic materials to international IVD manufacturers and research institutions, distribution of research reagents outside Japan through the Cosmo Bio USA partnership (formalized April 2025), and recurring revenue from the annual immunology precision-management survey service for Japanese clinical labs (35th edition conducted in 2026). Pricing is quote-based for IVD reagents and publicly listed for research antibodies at ¥36,750 per 20μg and ¥68,250 per 50μg.

Name

NITTOBO MEDICAL

Legal name

ニットーボーメディカル株式会社

Website

https://nittobo-nmd.co.jp

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

101–250 employees

Short description

NITTOBO MEDICAL is a Japanese in vitro diagnostics manufacturer (founded 1987, wholly-owned by Nittobo Co., Ltd.) that produces clinical chemistry and immunology reagents for automated analyzers, research antibodies, and antisera raw materials sourced from its own US goat farms, selling primarily to Japanese clinical laboratories and internationally via Cosmo Bio USA.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostic Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical Preparation Manufacturing (325412)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)

akta.pro primary industry

Clinical Chemistry & Immunoassay Systems (HLAHAAAA)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

Keywords

• In vitro diagnostic reagents
• Clinical chemistry analyzers
• Research antibodies
• Antisera raw materials
• Clinical laboratory reagents

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. In Vitro Diagnostic Reagents: Manufactures and sells clinical diagnostic reagents for automated biochemical analyzers. Products include bone metabolism markers (TRACP-5b), immunological markers (IgG4), and general biochemical items.
2. Research Antibodies: Sells research-use antibodies for immunohistochemistry, flow cytometry, and other research applications. Distributed domestically and internationally through partners.
3. Antisera and Raw Materials: Imports and sells antisera, human serum standards, and controls from US subsidiary to domestic in vitro diagnostic manufacturers and research institutions.
4. Quality Control Surveys: Conducts periodic precision management surveys for clinical laboratories (immunity item quality control surveys).

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

NITTOBO MEDICAL manufactures and sells in-vitro diagnostic drugs (clinical diagnostic reagents), antiserum, serum, and plasma for use on automated clinical biochemistry analyzers. The company also develops and distributes research antibodies for neuroscience and related fields, and provides antisera raw materials and quality control survey services for clinical laboratories. Its products span bone metabolism markers (TRACP-5b), immunological markers (IgG4), general biochemistry items (HbA1c, CRP, ALP, LD, AMY, calcium, iron), and biochemical standard solutions and controls.

Product overview

NITTOBO MEDICAL is a Japanese in vitro diagnostics company founded in 1987, developing and manufacturing clinical diagnostic reagents and research antibodies. The company operates as a subsidiary of Nittobo Co., Ltd. (100% owned) and maintains an integrated production system from raw materials to finished products within the Nittobo Group. The product portfolio includes: (1) In vitro diagnostic reagents for clinical biochemistry analyzers including N-Assay LA IgG4 Nittobo for IgG4-related diseases, TRACP-5b for bone metabolism, HbA1c, CRP, ALP, LD, calcium, and oxidized albumin; (2) Biochemical standard solutions and quality control materials including Trace Calib PLUS and L-Suitrol U; (3) Research antibodies for neuroscience and cancer research including immunohistochemistry antibodies, flow cytometry antibodies, VHH antibodies, and rapid BACpro®Ⅱ; (4) Anti-serum and biological materials including goat anti-serum for human immunoglobulins and human serum calibrators/controls sourced from Nittobo America Inc. The company offers products for biochemical, immunological, and molecular testing applications.

Differentiator

Problem solved

Functional benefit

Products and services

• N-Assay LA IgG4 Nittobo In vitro diagnostic reagent for measuring serum IgG4 levels on standard clinical biochemical analyzers. Uses monoclonal antibodies with high specificity for IgG4; measures up to 500 mg/dL without hook effect.
• TRACP-5b measurement reagent Bone metabolism marker reagent for measuring tartrate-resistant acid phosphatase-5b (TRACP-5b) on fully automated clinical inspection systems.
• N-assay LA HbA1c Nittobo In vitro diagnostic reagent for measuring glycated hemoglobin (HbA1c) in blood samples.
• N-assay LA CRP-U Nittobo In vitro diagnostic reagent for measuring C-reactive protein (CRP) levels.
• N-assay L LD-S IFCC Nittobo In vitro diagnostic reagent for measuring lactate dehydrogenase (LD) using the IFCC reference method.
• N-assay L ALP IFCC Nittobo In vitro diagnostic reagent for measuring alkaline phosphatase (ALP) using the IFCC reference method.
• N-assay LA FER-S Nittobo In vitro diagnostic reagent for measuring serum iron (FER) levels.
• L Ca-T Nittobo In vitro diagnostic reagent for measuring calcium levels in clinical settings.
• Oxidized Albumin (HNA) Nittobo In vitro diagnostic reagent for measuring oxidized albumin as an oxidative stress marker.
• N-assay L AMY G7 Nittobo In vitro diagnostic reagent for measuring amylase (AMY) levels.
• Trace Calib PLUS Biochemical standard solution for calibrating clinical chemistry analyzers.
• L-Suitrol U Quality control material for clinical laboratory testing.
• Goat Anti-serum Products High-quality goat anti-sera for human immunoglobulins (IgG, IgA, IgM, IgE), apolipoproteins, cardiac markers, and other serum proteins. Produced by Nittobo America Inc. with approximately 30 years of global sales history; sourced from company-owned goat farms in California, Iowa, and Maine.
• Human Serum Calibrators and Controls Calibrators including Apolipoprotein A1/B Calibrator, CRP Calibrator, Lp(a) Calibrator, and General Immunology Calibrator for various analytes.
• Human Special Specimens Special human specimens including deficient sera for apolipoprotein, CRP, and lipoprotein(a) testing.
• Immunohistochemistry Research Antibodies Quality-checked polyclonal antibodies for brain and nervous system research, covering neurotransmitters, receptors, transporters, and synaptic proteins. Validated using KO mouse samples for immunostaining.
• Flow Cytometry Research Antibodies Antibodies validated for flow cytometry applications.
• rapid BACpro® II Rapid preparation kit for bacterial identification and characterization.
• Anti-ACE2 Monoclonal Antibody Monoclonal antibody specifically reacting with ACE2 (angiotensin-converting enzyme II), the receptor for SARS-CoV-2, for basic research on SARS-CoV-2 transmission mechanisms.
• VHH Antibodies (Alpaca-derived) Alpaca-derived VHH antibodies including anti-SARS-CoV-2 variants, developed in collaboration with Kyoto University.

Quantifiable outcome

• Received manufacturing/marketing approval for TRACP-5b automated clinical diagnostic reagent
• +1 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Cosmo Bio USAcoreChannel Partner/ Reseller/ Distributor · 4 April 2025International distribution partner for laboratory reagents. Handles all product ordering and distribution for research antibodies and reagents outside Japan.
• Nittobo America Inc.coreStrategic or Co-development Partner · 28 August 1987Wholly-owned US subsidiary handling antisera production and supply. Operates goat farms in California (IIIC brand), Iowa (MBC brand), and Maine (CAP brand). Provides stable supply of high-quality antisera for in vitro diagnostic manufacturers worldwide.
• Fujikakoushi Co., Ltd. (藤倉化成株式会社)minorStrategic or Co-development PartnerJoint venture partnership for antisera distribution in Japanese market.
• Kamiya Biomedical Company, LLCminorStrategic or Co-development PartnerBusiness relationship for antisera and related products in the value chain.
• Fukushima Medical University (公立大学法人 福島県立医科大学)minorStrategic or Co-development PartnerCollaborative research partnership started in April 2021 for joint research initiatives.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Beckman Coulter (Danaher): Global IVD provider with clinical chemistry and immunoassay analyzers plus reagent menus. Comparable as a large incumbent in the same automated-analyzer workflow served by Nittobo Medical's clinical chemistry and immunoassay reagents.
• Roche Diagnostics: Global IVD leader offering the broadest portfolio of clinical chemistry, immunoassay, and specialty diagnostic reagents. The primary large-player competitor whose installed analyzer base defines the standard platforms (e.g., cobas) on which Nittobo Medical's open-system reagents run.
• Tosoh Corporation: Japanese chemical and diagnostics company producing IVD reagents, immunoassay systems, and clinical chemistry products. Overlaps with Nittobo Medical in clinical chemistry and immunoassay reagents for Japanese hospital and reference lab customers.
• Siemens Healthineers: Major global IVD provider with Atellica and ADVIA Centaur immunoassay/clinical chemistry systems and associated reagents. Comparable as an incumbent whose automated analyzer ecosystem shapes demand for open-system reagents like Nittobo Medical's.
• Sysmex Corporation: Leading Japanese in-vitro diagnostics company with a broader portfolio spanning hematology, immunoassay, and clinical chemistry analyzers plus reagents. Larger and more diversified than Nittobo Medical but operates in overlapping reagent categories and customer segments.
• Abbott Diagnostics: Global diagnostics business with extensive immunoassay and clinical chemistry reagent lines. Comparable as a benchmark incumbent whose scale and menu breadth set the competitive ceiling for specialty IVD players.

Direct peers

• Eiken Chemical Co., Ltd. Japanese specialty IVD company developing clinical chemistry, immunological, and microbiological diagnostic reagents for clinical laboratories. Directly comparable in product category (clinical chemistry/immunoassay reagents), customer base (Japanese clinical labs), and business model.
• Bio-Rad Laboratories: Global manufacturer of clinical diagnostics products and life science research reagents including antibodies and immunoassay kits. Comparable in both the IVD reagent and the research antibody / life science reagent businesses.
• Fujirebio (H.U. Group Holdings): Japanese specialty diagnostics company focused on immunoassay reagents including bone metabolism markers and other clinical chemistry parameters. A direct niche competitor in the specialty IVD reagent segment Nittobo Medical serves.
• Denka Co., Ltd. (Denka Seiken): Japanese diagnostics manufacturer (formerly Denka Seiken) producing IVD reagents for infectious diseases, immunology, and clinical chemistry. Comparable as a domestic Japanese IVD specialist serving the same clinical laboratory customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NITTOBO MEDICAL